Today, NNIT has published financial estimates gathered from the four equity analysts covering the NNIT share ahead of the Q3 2024 announcement scheduled for publication on November 5.
As a new practice, the estimates will be made available on NNIT’s investor site and announced one week before the quarterly announcement. The estimates can be found here:
https://www.nnit.com/investors-media/investors/share/analyst-coverage/
NNIT will host a webcast about the Q3 2024 announcement on November 6 at 9:30 CET. Details can be found via this link: https://www.nnit.com/investors-media/investors/calendar/
For more information, please contact:
Investor Relations
Carsten Ringius
EVP & CFO
Tel: +45 3077 8888
carr@nnit.com
Media Relations
Tina Joanne Hindsbo
Media Relations Manager
Tel: +45 3077 9578
tnjh@nnit.com
ABOUT NNIT
NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and private sectors in Denmark.
We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high.
We advise on and build sustainable digital solutions that work for the patients, citizens, employees, end users or customers.
We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies, but always driven by business needs rather than technology.
NNIT consists of group company NNIT A/S and subsidiaries SCALES, Excellis Health Solutions and SL Controls. Together, these companies employ more than 1,700 people in Europe, Asia and USA. Read more at http://www.nnit.com.
Attachment
